Latest Biotech News

Promising novel therapies and platforms for neurological disorders are emerging. Aerska launched with $21 million seed funding to develop RNAi drugs targeting the brain, advancing treatments for...

Single-cell RNA sequencing technologies are rapidly scaling up due to advances in automation and improved chemistries. Companies like SPT Labtech integrate automated liquid handling with leading...

Novel AI models and computational tools are enabling breakthroughs in molecular biology. The trimodal protein language model ProTrek integrates sequence, structure, and functional descriptions,...

Researchers worldwide are making crucial advances in cancer biology and treatment. Organoid models derived from primary and xenograft ovarian tumors show promise in predicting platinum therapy...

Recent breakthroughs in artificial intelligence and genomic technologies are revolutionizing protein research and production. New methods like ProTrek integrate multimodal protein language models...

Japanese pharmaceutical giant Takeda has announced a complete halt to all cell therapy research and development activities as part of its strategic portfolio prioritization. After building...

Pfizer has reached an agreement with the Trump administration to offer medicines at prices comparable to those found in other developed countries, marking the first drug maker to sign on under the...

Danish biotech leader Genmab has announced an $8 billion all-cash acquisition of Merus, a clinical-stage bispecific antibody specialist well-known for petosemtamab, its lead EGFRxLGR5 bispecific...

Recent studies reveal transformative innovations in oncology diagnostics and treatment modalities. AI-driven radiomics and multi-modal models are enhancing detection and prognosis in pancreatic,...

Groundbreaking research links neurodegenerative diseases such as ALS and Parkinson’s to autoimmune processes involving T cell responses to neuronal proteins like C9orf72. Novel imaging techniques,...

Recent studies have expanded capabilities in stem cell biology and regenerative medicine. USC researchers have successfully cultured authentic embryonic stem cells from multiple bird species using...

The integration of artificial intelligence and digital platforms is accelerating drug discovery and clinical research. Pharma companies are pooling proprietary structural data for training large...

Regulatory agencies face operational challenges due to government funding uncertainties, affecting drug submissions and approvals. The FDA is suspending acceptance of new drug submissions amid a...

Enzymes continue to transform biotechnology and industrial processes through sustainable, efficient biocatalysis. Their role extends beyond food and beverage, impacting textiles, pharmaceuticals,...

Takeda Pharmaceutical has announced the complete discontinuation of its cell therapy research and development efforts, including layoffs of 137 employees in Massachusetts. The decision follows a...

The U.S. Food and Drug Administration approved Novartis's oral Bruton’s tyrosine kinase inhibitor, remibrutinib (branded as Rhapsido), as a second-line treatment for chronic spontaneous urticaria...

Pfizer has become the first pharmaceutical company to agree to the Trump administration's most-favored nation pricing initiative, committing to sell select medicines in the United States at prices...

Artificial intelligence technologies are demonstrating significant breakthroughs in oncology, ranging from automated segmentation and prediction of metastatic spread using imaging, to the...

Researchers have developed cutting-edge software and techniques enhancing analysis of spatial multiomics data, a pivotal advance for understanding tissue microenvironments and disease mechanisms...

Advances in gene editing and DNA synthesis technologies are accelerating biotech innovation. Companies are pursuing novel editing platforms that improve precision and extend beyond CRISPR, while...